Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V de Haas

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|August 30, 2002
Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?V De Haas, G J L Kaspers, L Oosten, et al.
Leukemia|September 5, 2012
Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemiaB Denys, A J van der Sluijs-Gelling, C Homburg, et al.
British Journal of Haematology|February 14, 2002
The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemiaV de Haas, W B Breunis, R Dee, et al.
Leukemia|August 17, 2012
The clinical relevance of BAALC and ERG expression levels in pediatric AMLM C H Hermkens, M M van den Heuvel-Eibrink, S T C J M Arentsen-Peters, et al.
Leukemia|August 8, 2012
BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemiaT D Buitenkamp, R Pieters, M Zimmermann, et al.
Leukemia|June 8, 2011
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groupsF Damm, F Thol, I Hollink, et al.
Leukemia|December 21, 2018
Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortalityA M J Reedijk, K Klein, J W W Coebergh, et al.
Leukemia|September 4, 2012
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic targetS A Hartsink-Segers, C M Zwaan, C Exalto, et al.
Leukemia|December 14, 2011
Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletionN C Venn, V H J van der Velden, M de Bie, et al.
Stem Cell Research|February 14, 2015
Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitroF G J Calkoen, C Vervat, M van Pel, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|August 30, 2002
Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?V De Haas, G J L Kaspers, L Oosten, et al.
Leukemia|September 5, 2012
Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemiaB Denys, A J van der Sluijs-Gelling, C Homburg, et al.
British Journal of Haematology|February 14, 2002
The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemiaV de Haas, W B Breunis, R Dee, et al.
Leukemia|August 17, 2012
The clinical relevance of BAALC and ERG expression levels in pediatric AMLM C H Hermkens, M M van den Heuvel-Eibrink, S T C J M Arentsen-Peters, et al.
Leukemia|August 8, 2012
BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemiaT D Buitenkamp, R Pieters, M Zimmermann, et al.
Leukemia|June 8, 2011
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groupsF Damm, F Thol, I Hollink, et al.
Leukemia|December 21, 2018
Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortalityA M J Reedijk, K Klein, J W W Coebergh, et al.
Leukemia|September 4, 2012
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic targetS A Hartsink-Segers, C M Zwaan, C Exalto, et al.
Leukemia|December 14, 2011
Highly sensitive MRD tests for ALL based on the IKZF1 Δ3-6 microdeletionN C Venn, V H J van der Velden, M de Bie, et al.
Stem Cell Research|February 14, 2015
Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitroF G J Calkoen, C Vervat, M van Pel, et al.
Pageof 5